<?xml version="1.0" encoding="UTF-8"?>
<p>The pre-defined primary study outcome was HIV incidence between PC12 and PC36, comparing Arm A and Arm B to Arm C. This approach provided one year to fully establish the study intervention before measuring study outcomes. Other outcomes reported here include viral suppression (VS, &lt; 400 copies HIV RNA/ml) and the estimated coverage of HIV testing and ART based on CHiPs data from Arms A and B.</p>
